Skip to content

#Therapy models

28 OctWed
  1. OPEN Foundation62

    OPEN Foundation reviews study on how psilocybin aligns brain activity with sensory context

    OPEN Foundation summarises a study by Stoliker and colleagues, described as the largest single-site psychedelic neuroimaging study to date, in which 62 healthy adults aged 18 to 55 with no previous meaningful psychedelic experience received a single 19 mg oral dose of psilocybin and underwent fMRI and EEG recordings across rest, guided meditation, music listening and movie viewing.

19 OctMon
  1. The Microdose (UC Berkeley BCSP)41

    Maastricht psychopharmacologists Mason and Haijen-Bongers call for research on menstrual cycle effects in psychedelic trials

    Psychopharmacologists Natasha Mason and Eline Haijen-Bongers argue that clinical trials of psychedelics for depression and PTSD rarely account for female sex hormones, in a review in Nature Molecular Psychiatry. They cite a preprint pooling their psychedelic trial data in which women given the same dose responded more strongly and reported greater anxious ego dissolution. The review notes 5-HT2A receptor density rises when estrogen is high.

6 SepSun
  1. Europe PMC: new psychedelic research papers60

    Systematic review examines the effect of psychedelics on associative learning

    A systematic review of 62 studies, only 2 in humans, reports that psychedelic administration appears to enhance associative learning in animals across conditioning paradigms, though findings were not consistent. The authors write that direct evidence of enhanced associative learning in humans remains limited, while human studies show altered cognitive flexibility and learning-related processes.

    Why it matters: The review separates animal evidence of enhanced associative learning from the limited human data, a distinction that matters for claims about the post-acute window used in psychedelic-assisted psychotherapy.

20 MayWed
18 MayMon